Partial recovery from alloxan-induced diabetes by sodium phthalhydrazide in rats

Biomedicine and Pharmacotherapy

Volumn 95, Issue , 2017, Pages 103-110

  Danilova, Irina G ^a,b   Bulavintceva, Tatyana S ^a,b   Gette, Irina F ^a,b   Medvedeva, Svetlana Yu ^a,b   Emelyanov, Victor V ^a   Abidov, Musa T ^c  

^a URAL FEDERAL UNIVERSITY   (Russian Federation)

^b INSTITUTE OF IMMUNOLOGY AND PHYSIOLOGY   (Russian Federation)

^c Institute of Immunopatology   (Russian Federation)

Author keywords

Alloxan induced diabetes; Heterocyclic N hydrazides; Luminol derivative; Pancreatic cell; Phthalhydrazide; Type 1 diabetes

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; CORTICOSTERONE; GALAVIT; GLUCOSE; HEMOGLOBIN A1C; HYDRAZIDE DERIVATIVE; INSULIN; INTERLEUKIN 6; SODIUM PHTHALHYDRAZIDE; SOMATOMEDIN; TAMERIT; UNCLASSIFIED DRUG; GLYCOSYLATED HEMOGLOBIN; HYDRAZINE DERIVATIVE; PHTHALAZINE DERIVATIVE;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MACROPHAGE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; ANIMAL; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLYCATED HEMOGLOBIN A; HYDRAZINES; HYPOGLYCEMIC AGENTS; PHTHALAZINES; RATS;

EID: 85027889878     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.07.117     Document Type: Article

References (66)

1. Radenkovic, M., Stojanovic, M., Prostan, M., Experimental diabetes induced by alloxan and streptozotocin: the current state of art. J. Pharmacol. Toxicol. Meth. 78 (2016), 13–31.
2. Lenzen, S., The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51 (2008), 2016–2226.
3. Szkudelski, T., The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Rev. 50 (2001), 536–546.
4. Al-awar, A., Kupai, K., Veszelka, M., Szűcs, G., Attieh, Z., Murlasits, Z., Török, S., Pósa, A., Varga, C., Experimental diabetes mellitus in different animals models. J. Diabet. Res., 2016, 2016 9051426.
5. Battaglia, M., Atkinson, M.A., The streetlight effect in type 1 diabetes. Diabetes 64 (2015), 1081–1890.
6. Yoon, J.W., Jun, H.S., Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Ann. N. Y. Acad. Sci. 928 (2001), 200–211.
7. Morel, P.A., Dendritic cell subsets in type 1 diabetes: friend or foe?. Front. Immunol., 4, 2013, 415.
8. Lee, K.U., Kim, M.K., Amano, K., Pak, C.Y., Jaworski, M.A., Mehta, J.G., Yoon, J.W., Preferential infiltration of macrophages during early stages of insulinitis in diabetes-prone BB rats. Diabetes 37 (1988), 1053–1058.
9. Willcox, A., Richardson, S.J., Bone, A.J., Foulis, A.K., Morgan, N.G., Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol. 155 (2009), 173–181.
10. Price, J.D., Tarbell, K.V., The role of dendritic cell subsets and innate immunity in the pathogenesis of type 1 diabetes and other autoimmune diseases. Front. Immunol., 6, 2015, 288.
11. Gusdon, A.M., Corbett, J.A., Mathews, C.E., Type 1 diabetes: islet inflammation −the contribution of cytokines and beta-cells. Drug Discov. Today Dis. Mech. 3 (2006), 367–372.
12. Pastorale, C., Arata, M., Caminos, A., Bruno, L., Basabe, J., Chemes, H., Effect of modified diabetic splenocytes on mice injected with multiple low-dose streptozotocin. Exp. Biol. Med. (Maywood) 227 (2002), 282–289.
13. Zheng, D., Wang, Y., Cao, Q., Lee, V.W., Zheng, G., Sun, Y., Tan, T.K., Wang, Y., Alexander, S.I., Harris, D.C., Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus. Nephron Exp. Nephrol. 118 (2011), e87–99.
14. Parsa, R., Andresen, P., Gillett, A., Mia, S., Zhang, X.M., Mayans, S., Holmberg, D., Harris, R.A., Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes 61 (2012), 2881–2892.
15. Xiao, X., Gittes, G.K., Concise review: new insights into the role of macrophages in β-cell proliferation. Stem Cell. Transl. Med. 4 (2015), 655–658.
16. Clayton, H.W., Osipovich, A.B., Stancill, J.S., Schneider, J.D., et al. Pancreatic inflammation redirects acinar to β-cell reprogramming. Cell Rep. 17 (2016), 2028–2041.
17. Saunders, D., Powers, A.C., Replicative capacity of β-cells and type 1 diabetes. J. Autoimmun. 71 (2016), 59–68.
18. Dao, T.V., Casas, A.I., Maghzal, G.J., Seredinina, T., Kaludercic, N., Robledinos-Anton, N., Di Lisa, F., Stocker, R., Ghezzi, P., Jaquet, V., Cuadrado, A., Schmidt, H.H., Pharmacology and clinical drug candidates in redox medicine. Antioxid. Redox Signal 23 (2015), 1113–1125.
19. Abidov, M.T., New N-heterocyclic pharmaceuticals for humans. Almanach (Pol.) 11 (2016), 74–80.
20. Hapravlennaia immunokorrekcia: problemy, perspektivy. Abidov, M.T., (eds.) Directive Immunocorrection: Problems and Perspectives, 2000, Izdatielstvo RAMN, Moscow.
21. Nagoev, B.C., Abidov, M.T., Ponezeva, Z.B., Chroniczeskije virusnyje giepatity: immunopatologiczeskije, kliniko-diagnosticzeskije i terapeuticzeskije aspekty (Russian). Chronic Viral Hepatitis: Immunopathogenetic, Clinical-diagnostic and Therapeutic Aspects, 2005, Guripp Adigea, Maikop.
22. Hübner, J., Münster, J., Alternative therapien in der onkologie. Onkologe 15 (2009), 912–921.
23. Goskov, I.A., Kiselnikova, L.P., Danilova, I.G., Goldstein, E.W., Abidov, M.T., Ocenka kliniceskoj effektivnosti immunomodulatora v kompleksnom lecenii vospalitelno-destruktivnych zabolevanii parodonta (Russian) [Estimation of clinical efficiency of the immunomodulator medicine in complex treatment of periodontal diseases] Part I. Kliniceskaja Stomatologia 4 (2011), 18–19.
24. Goskov, I.A., Kiselnikova, L.P., Danilova, I.G., Goldstein, E.W., Ocenka, M.T., kliniceskoj effektivnosti immunomodulatora v kompleksnom lecenii vospalitelno-destruktivnych zabolevanii parodonta (Russian) [Estimation of clinical efficiency of the immunomodulator medicine in complex treatment of periodontal diseases] Part II. Kliniceskaja Stomatologia 1 (2012), 38–41.
25. Rybakov, V.B., Chernyshev, V.V., Paseshnichenko, K.A., Sheludyakov, V.D., Belyakov, N.G., Boziev, R.S., Mochalov, V.N., Storozhenko, P.A., On the structure of luminal sodium salts. Crystallogr. Rep. 59 (2014), 383–393.
26. Karpischev, A.I., Medical Laboratory Technology. 2002, Intermedika, St. Petersburg (in Russian).
27. Yakovleva, G.E., The Enzymes in Clinical Biochemistry. 2005, Vector-Best, Novosibirsk.
28. Jeppsson, J.O., Kobold, U., Barr, J., Finke, A., Hoelzel, W., Hoshino, T., Miedema, K., Mosca, A., Mauri, P., Paroni, R., Thienpont, L., Umemoto, M., Weykamp, C., Approved IFCC reference method for the measurement of HbA1c in human blood. Clin. Chem. Lab. Med. 40 (2002), 78–89.
29. Kumar, G.L., Rudbeck, L., Education Guide. Immunohistochemical (IHC) Staining Methods. 2009, California: Dako North America, Carpinteria, 224.
30. Taylor, R.R., Martinez-Pomares, L., Stacey, M., Lin, H.H., Brown, G.D., Gordon, S., Macrophage receptors and immune recognition. Ann. Rev. Immunol. 23 (2005), 901–944.
31. Brochhausen, C., Schmitt, V.H., Mamilos, A., Schmitt, C., Planck, C.N., Rajab, T.K., Hierlemann, H., Kirkpatrick, C.J., Expression of CD68 positive macrophages in the use of different barrier materials to prevent peritoneal adhesions −an animal study. J. Mater. Sci. Mater. Med. 28 (2017), 15–30.
32. Takemoto, K., Doi, W., Masuoka, N., Protective effect of vitamin E against alloxan-induced mouse hyperglycemia. Biochim. Biophys. Acta 1862 (2016), 647–650.
33. Panveloski-Costa, A.C., Teixeira, S.S., Ribeiro, I.M., Serrano-Nascimento, C., das Neves, R.X., Favaro, R.R., Seelaender, M., Antunes, V.R., Nunes, M.T., Thyroid hormone reduces inflammatory cytokines improving glycaemia control in alloxan-induced diabetic wistar rats. Acta Physiol. (Oxf.) 217 (2016), 130–140.
34. Zhang, D., Wang, F., Lal, N., Chiu, A.P., Wan, A., Jia, J., Bierende, D., Flibotte, S., Sinha, S., Asadi, A., Hu, X., Taghizadeh, F., Pulinilkunnil, T., Nislow, C., Vlodavsky, I., Johnson, J.D., Kieffer, T.J., Hussein, B., Rodrigues, B., Heparanase overexpression induces glucagon resistance and protects animals from chemically induced diabetes. Diabetes 66 (2017), 45–57.
35. Eo, H., Lee, J.H., Lim, Y., Ameliorative effect of dietary genistein on diabetes induced hyper-inflammation and oxidative stress during early stage of wound healing in alloxan-induced diabetic mice. Biochem. Biophys. Res. Commun. 478 (2016), 1021–1027.
36. Durg, S., Veerapur, V.P., Neelima, S., Dhanne, S.B., Antidiabetic activity of Embelia ribes: embelin and its derivatives: a systematic review and meta-analysis. Biomed. Pharmacother. 86 (2017), 195–204.
37. 1H NMR-based metabolomic approach unravels antidiabetic activity of genipin and its possible mechanism. J. Pharm. Biomed. Anal. 129 (2016), 80–89.
38. Liu, Z., Zhai, J., Han, J.N., Yin, J., Assessment of anti-diabetic activity of the aqueous extract of leaves of Astilboides tabularis. J. Etnopharmacol. 194 (2016), 635–641.
39. Ramadan, B.K., Schaalan, M.F., Tolba, A.M., Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats. BMC Complement Altern. Med., 17, 2017, 3747, 10.1186/s12906-016-1530-1.
40. Cherbal, A., Kebieche, M., Yilmaz, E., Aydogmus, Z., Benzaouia, L., Benguessoum, M., Benkedidah, M., Madani, K., Antidiabetic and hypolipidemic activities of Algerian Pistachia lentiscus L leaves extract in alloxan-induced diabetic rats. South Afr. J. Bot. 108 (2017), 157–162.
41. Rafieian-Kopaei, M., Effect of hydroalcoholic Allium ampeloprasum extract on oxidative stress: diabetes mellitus and dyslipidemia in alloxan-induced diabetic rats. Biomed. Pharmacother. 86 (2017), 363–367.
42. Rahimi-Madiseh, M., Heidarian, E., Kheiri, S., Heidarian, E., Kheiri, S., Rafieian-Kopaei, M., Effect of hydroalcoholic Allium ampeloprasum extract on oxidative stress: diabetes mellitus and dyslipidemia in alloxan-induced diabetic rats. Biomed. Pharmacother. 86 (2017), 363–367.
43. Darvhekar, V., Tirpathi, A.S., Jyotishi, S.G., Mazumder, P.M., Shelke, P.G., Influence of Musa sapientum L. on pharmacokinetic of metformin in diabetic gastroparesis. Chin. J. Integr. Med. 22 (2016), 783–788.
44. Roy, V.K., Chenkual, L., Gurusubramanian, G., Malotus roxburghianus modulates antioxidant responses in pancreas of diabetic rats. Acta Histochem. 118 (2016), 152–163.
45. Mahmoud, M.F., El Ashry, F.E., El Maraghy, N.N., Fahmy, A., Studies on the antidiabetic activities of momordica charantia fruit juice in streptozotocin-induced diabetic rats. Pharm. Biol. 55 (2017), 758–765.
46. Chakroun, M., Khemakhem, B., Mabrouk, H.B., El Abed, H., Makini, M., Bouaziz, M., Dira, N., Marrakchi, N., Mejdoub, H., Evaluation of anti-diabetic and anti-tumoral activities of bioactive compounds from Phoenix dactylifera L's leaf: in vitro and in vivo approach. Biomed. Pharmacother. 84 (2016), 415–422.
47. Zhao, Y., Huang, Z., Lazzarini, P., Wang, Y., Di, A., Chen, M., A unique human blood-derived cell population displays high potential for producing insulin. Biochem. Biophys. Res. Commun. 360 (2007), 205–2011.
48. Criscimanna, A., Coudriet, G.M., Gittes, G.K., Piganelli, J.D., Esni, F., Activated macrophages create lineage-specific microenvironments for pancreatic acinar- and β-cell regeneration in mice. Gastroenterol 147 (2014), 1106–1118.
49. Espinoza-Jiménez, A., Peón, A.N., Terrazas, L.I., Alternatively activated macrophages in types 1 and 2 diabetes. Mediat. Inflamm., 2012, 815953 ([Internet] 2012 Dec 27 [cited 2016 August 22]).
50. Jetten, N., Verbruggen, S., Gijbels, M.J., Post, M.J., De Winther, M.P., Donners, M.M., Anti-inflammatory M2: but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 17 (2014), 109–118.
51. Wang, N., Liang, H., Zen, K., Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front. Immunol. 5 (2014), 614–622.
52. Van Sickle, B.J., Simmons, J., Hall, R., Raines, M., Ness, K., Spagnoli, A., Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus. Cytokine 48 (2009), 290–294.
53. ​ Thrailkill, K.M., Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol. Ther. 2 (2000), 69–80.
54. ​ Mohamed-Ali, V., Pinkney, J., Therapeutic potential of insulin-like growth factor-1 in patients with diabetes mellitus. Treat. Endocrinol. 1 (2002), 399–410.
55. Xuan, ​S., Kitamura, T., Nakae, J., Politi, K., Kido, Y., Fisher, P.E., Morroni, M., Cinti, S., White, M.F., Herrera, P.L., Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor. J. Clin. Invest. 110 (2002), 1011–1019.
56. Petrik, J., Arany, E., McDonald, T.J., Hill, D.J., Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinol 139 (1998), 2994–3004.
57. Petrik, J., Reusens, B., Arany, E., Remacle, C., Coelho, C., Hoet, J.J., Hill, D.J., A low protein diet alters the balance of islet cell replication and apoptosis in the fetal and neonatal rat and is associated with a reduced pancreatic expression of insulin-like growth factor-II. Endocrinol 140:199 (2016), 4861–4873.
58. Mills, C.D., Anatomy of a discovery: m1 and m2 macrophages. Front. Immunol. 6 (2015), 212–219.
59. Withers, D.J., Burks, D.J., Towery, H.H., Altamuro, S.L., Flint, C.L., White, M.F., Irs-2 coordinates Igf-1 receptor-mediated beta-сell development and peripheral insulin signalling. Nat. Genet. 23 (1999), 32–40.
60. Xiao, X., Gaffar, I., Guo, P., Wiersch, J., Fischbach, S., Peirish, L., Song, Z., El-Gohary, Y., Prasadan, K., Shiota, C., Gittes, G.K., M2 macrophages promote beta-cell proliferation by upregulation of SMAD7. Proc. Nat. Acad. Sci. U. S. A. 111 (2014), E1211–2120.
61. Bulavintseva, T.S., Medvedeva, S.Y., Gette, I.F., Abidov, M.T., Effect of the macrophage link of the immune system activation on the state of the spleen and thymus in alloxan diabetes. Med. Immunol. 4–5 (2009), 305–306 (in Russian).
62. Jukić, T., Abidov, M.T., Ihan, A., A tetrahydrophthalazine derivative sodium nucleinate exerts a potent suppressive effect upon LPS-stimulated mononuclear cells in vitro and in vivo. Coll. Antropol. 35 (2011), 1219–1223.
63. + cells of different localization after liver damage in mice. Bull. Experim. Biol. Med. 157 (2014), 357–359.
64. Jukić, T., Ihan, A., Jukić, D., Tetrahydrophthalazine derivative sodium nucleinate exert its anti-inflammatory effects through inhibition of oxidative burst in human monocytes. Coll. Antropol. 36 (2012), 409–412.
65. Yu, E., Goto, M., Ueta, H., Kitazawa, Y., Sawanobori, Y., Kariya, T., Sasaki, M., Matsuno, K., Expression of area-specific M2-macrophage phenotype by recruited rat monocytes in duct-ligation pancreatitis. Histochem. Cell Biol. 145 (2016), 659–673.
66. Van Gassen, N., Van Overmeire, E., Leuckx, G., Heremans, Y., De Groef, S., Cai, Y., Elkrim, Y., Gysemans, C., Stijlemans, B., Van de Casteele, M., De Baetselier, P., De Leu, N., Heimberg, H., Van Ginderachter, J.A., Macrophage dynamics are regulated by local macrophage proliferation and monocyte recruitment in injured pancreas. Eur. J. Immunol. 45 (2015), 1482–1493.